Your session is about to expire
← Back to Search
App for Monitoring Chemotherapy Side Effects in Breast Cancer
N/A
Recruiting
Research Sponsored by Julie Lemieux
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights
Summary
This trial is aimed at exploring the use of a web-based patient portal to improve the monitoring of oral therapy toxicities in breast cancer patients.
Who is the study for?
This trial is for adults over 18 with metastatic breast cancer who are currently taking oral chemotherapy drugs like palbociclib, everolimus, or capecitabine. Participants need to have a smartphone, tablet, or computer. Those with cognitive impairments cannot join.Check my eligibility
What is being tested?
The study is testing an app designed to help patients self-report side effects from oral chemotherapy treatments. The goal is to see if this can improve patient care and safety by providing systematic monitoring outside of the hospital setting.See study design
What are the potential side effects?
While not directly related to the app being tested, the oral chemotherapies involved may cause side effects such as nausea, fatigue, diarrhea, low blood cell counts leading to increased infection risk and other specific drug-related toxicities.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Number of calls
Trial Design
1Treatment groups
Experimental Treatment
Group I: ApplicationExperimental Treatment1 Intervention
Find a Location
Who is running the clinical trial?
Julie LemieuxLead Sponsor
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You must have breast cancer that has spread to other parts of the body.You have been diagnosed with advanced breast cancer that has spread to other parts of the body.You are currently taking certain types of chemotherapy pills, such as palbociclib, everolimus, or capecitabine.You have problems with memory or thinking.
Research Study Groups:
This trial has the following groups:- Group 1: Application
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger